Meridian Life Science Expands Ambient-Stable NGS Portfolio with the Launch of a Lyophilized Enzymatic DNA Fragmentation Kit

The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced the launch of its Lyophilized NGS ...

Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample

Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...
Mena FN

Next Generation Sequencing (NGS) Market To Reach US$33.3 Bn By 2032 Persistence Market Research

(MENAFN- EIN Presswire) EINPresswire/ -- The global Next Generation Sequencing (NGS) market is witnessing rapid expansion, driven by technological innovation and the growing importance of genomics in ...
GEN

Empowering NGS Research with Automated Vendor-Qualified Methods

NGS continually delivers breakthroughs in genomics, and to do so, it relies on the crucial step of sample preparation. Complex and expensive workflows are significant challenges. At Revvity, we are ...
MarketWatch

Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.

SAN FRANCISCO, Nov. 13, 2025 /PRNewswire/ -- The global next-generation sequencing market size is anticipated to reach USD 42.25 billion by 2033, growing at a CAGR of 18.0% from 2025 to 2033. The next ...
The American Journal of Managed Care

In Myeloid Neoplasms, Next-Generation Sequencing Can Be Inappropriate—and Money-Wasting

Criteria for NGS testing in MNs can reduce unnecessary tests, saving costs without affecting patient care quality. Six approval and six cancellation criteria guide appropriate NGS use, focusing on ...
ascopubs.org

Next-Generation Sequencing of Intraoperatively Acquired Cerebrospinal Fluid and Matched Tumor Tissue in Patients Undergoing Surgical Resection for Glioblastoma

We enrolled 50 patients undergoing resection of newly diagnosed (n = 15) or recurrent (n = 35) GBM. CSF was collected intraoperatively via the subarachnoid space (n = 25) or lateral ventricle (n = 25) ...
technologynetworks

Next-Generation Sequencing (NGS): Stimulating the Next Generation of Cancer Diagnostics and Treatment

, as defined by the Food and Drug Administration (FDA), can serve diagnostic, prognostic, predictive, and pharmacodynamics purposes in cancer and other diseases. Diagnostic biomarkers are ...